Hiroshi Iwamoto

3.0k total citations
158 papers, 2.1k citations indexed

About

Hiroshi Iwamoto is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, Hiroshi Iwamoto has authored 158 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Pulmonary and Respiratory Medicine, 37 papers in Oncology and 28 papers in Physiology. Recurrent topics in Hiroshi Iwamoto's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (48 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (28 papers) and Lung Cancer Treatments and Mutations (17 papers). Hiroshi Iwamoto is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (48 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (28 papers) and Lung Cancer Treatments and Mutations (17 papers). Hiroshi Iwamoto collaborates with scholars based in Japan, Finland and United States. Hiroshi Iwamoto's co-authors include Noboru Hattori, Kazunori Fujitaka, Hironobu Hamada, Takeshi Masuda, Nobuoki Kohno, Taku Nakashima, Yasushi Horimasu, Shintaro Miyamoto, Kakuhiro Yamaguchi and Nobuhisa Ishikawa and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Hiroshi Iwamoto

142 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroshi Iwamoto Japan	26	1.2k	407	366	308	196	158	2.1k
Mark G. Jones United Kingdom	20	2.3k 1.9×	397 1.0×	195 0.5×	608 2.0×	232 1.2×	70	3.3k
Mario Santini Italy	27	1.3k 1.1×	276 0.7×	421 1.2×	400 1.3×	790 4.0×	217	2.6k
Huaping Dai China	28	1.4k 1.1×	376 0.9×	150 0.4×	594 1.9×	351 1.8×	144	2.4k
Ren Yuan China	20	1.3k 1.0×	398 1.0×	147 0.4×	378 1.2×	127 0.6×	62	2.3k
Akira Igarashi Japan	24	505 0.4×	489 1.2×	266 0.7×	620 2.0×	366 1.9×	101	2.4k
Kosmas Tsakiridis Greece	32	1.7k 1.4×	236 0.6×	385 1.1×	297 1.0×	955 4.9×	122	2.8k
Jason Jungsik Song South Korea	27	722 0.6×	268 0.7×	307 0.8×	695 2.3×	308 1.6×	215	2.7k
Nathan Sandbo United States	24	543 0.4×	269 0.7×	232 0.6×	837 2.7×	398 2.0×	56	2.3k
C. Magnus Sköld Sweden	30	1.1k 0.9×	750 1.8×	193 0.5×	677 2.2×	230 1.2×	65	2.8k
William D. Hardie United States	29	1.5k 1.2×	337 0.8×	235 0.6×	544 1.8×	336 1.7×	68	2.3k

Countries citing papers authored by Hiroshi Iwamoto

Since Specialization

Citations

This map shows the geographic impact of Hiroshi Iwamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Iwamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Iwamoto more than expected).

Fields of papers citing papers by Hiroshi Iwamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Iwamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Iwamoto. The network helps show where Hiroshi Iwamoto may publish in the future.

Co-authorship network of co-authors of Hiroshi Iwamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Iwamoto. A scholar is included among the top collaborators of Hiroshi Iwamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Iwamoto. Hiroshi Iwamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Masuda, Takeshi, Kakuhiro Yamaguchi, Yasushi Horimasu, et al.. (2025). Plasminogen Activator Inhibitor-1 Mediates Tolerance to Anti–PD-1 Immunotherapy in Non–Small Cell Lung Cancer. Molecular Cancer Therapeutics. 25(3). 435–447. 1 indexed citations

Yamaguchi, Kakuhiro, Shinjiro Sakamoto, Yasushi Horimasu, et al.. (2025). Predictive Value of Circulatory Total VEGF-A and VEGF-A Isoforms for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small-Cell Lung Cancer. Cancers. 17(4). 572–572. 1 indexed citations

Miura, Shin‐ichiro, Hiroshi Iwamoto, Masashi Namba, et al.. (2024). High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis. BMJ Open Respiratory Research. 11(1). e001803–e001803. 10 indexed citations

Nakashima, Taku, Takeshi Masuda, Masashi Namba, et al.. (2023). Hypoxia-inducible factor 1α modulates interstitial pneumonia-mediated lung cancer progression. Journal of Translational Medicine. 21(1). 857–857. 2 indexed citations

Nakashima, Taku, Takeshi Masuda, Shinjiro Sakamoto, et al.. (2023). Nestin and Notch3 collaboratively regulate angiogenesis, collagen production, and endothelial–mesenchymal transition in lung endothelial cells. Cell Communication and Signaling. 21(1). 247–247. 6 indexed citations

Nakashima, Taku, Keitaro Omori, Masashi Namba, et al.. (2023). Serum and bronchoalveolar lavage fluid levels of soluble B7H3 in patients with interstitial lung diseases. Respiratory Medicine. 212. 107224–107224. 2 indexed citations

Masuda, Takeshi, Taku Nakashima, Masashi Namba, et al.. (2023). Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial–Mesenchymal Transition. Cancers. 15(4). 1092–1092. 5 indexed citations

Yamada, Takahiro, Taku Nakashima, Takeshi Masuda, et al.. (2023). Intestinal overgrowth of Candida albicans exacerbates bleomycin‐induced pulmonary fibrosis in mice with dysbiosis. The Journal of Pathology. 261(2). 227–237. 6 indexed citations

Omori, Keitaro, Hiroki Kitagawa, Kakuhiro Yamaguchi, et al.. (2023). Clinical characteristics of extrapulmonary nontuberculous mycobacteria infections in comparison with pulmonary infections: A single-center, retrospective study in Japan. Journal of Infection and Chemotherapy. 29(9). 875–881. 12 indexed citations

10.

Iwamoto, Hiroshi, Shintaro Miyamoto, Satoshi Nakao, et al.. (2022). Association Between Patient Preference for Inhaler Medications and Asthma Outcomes. Journal of Asthma and Allergy. Volume 15. 1539–1547. 2 indexed citations

11.

Yamaguchi, Kakuhiro, Koji Kurose, Satoshi Nakao, et al.. (2022). Predictive value of serum high‐mobility group box 1 levels for checkpoint inhibitor pneumonitis. Respirology. 28(4). 380–388. 1 indexed citations

12.

Lenshin, A. S., Juliy M. Perelman, Yu Matsumoto, et al.. (2021). P1‐55: Pulmonary function after nintedanib treatment in post‐COVID‐19 pulmonary fibrosis. Respirology. 26(S3). 94–95.

13.

Yamaguchi, Kakuhiro, Shinjiro Sakamoto, Yasushi Horimasu, et al.. (2021). Risk factors associated with increased discontinuation rate of trimethoprim–sulfamethoxazole used as a primary prophylaxis for Pneumocystis pneumonia: A retrospective cohort study. Pulmonary Pharmacology & Therapeutics. 67. 101999–101999. 3 indexed citations

14.

Miura, Shin‐ichiro, Hiroshi Iwamoto, Keitaro Omori, et al.. (2021). Accelerated decline in lung function in adults with a history of remitted childhood asthma. European Respiratory Journal. 59(1). 2100305–2100305. 10 indexed citations

15.

Takahashi, Hiroshi, Taku Nakashima, Takeshi Masuda, et al.. (2021). Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity. Stem Cell Research & Therapy. 12(1). 471–471. 6 indexed citations

16.

Horimasu, Yasushi, Kakuhiro Yamaguchi, Shinjiro Sakamoto, et al.. (2021). IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis. PLoS ONE. 16(6). e0252594–e0252594. 13 indexed citations

17.

Gao, Jing, Chuanxing Li, Steffen Ohlmeier, et al.. (2020). <p>Sputum Vitamin D Binding Protein (VDBP) GC1S/1S Genotype Predicts Airway Obstruction: A Prospective Study in Smokers with COPD</p>. International Journal of COPD. Volume 15. 1049–1059. 9 indexed citations

18.

Namba, Masashi, Noboru Hattori, Hironobu Hamada, et al.. (2018). Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1. Cancer Letters. 442. 31–39. 15 indexed citations

19.

Nakashima, Taku, Hironobu Hamada, Takeshi Masuda, et al.. (2018). Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma. European Respiratory Journal. 51(5). 1701610–1701610. 15 indexed citations

20.

Hattori, Noboru, Hironobu Hamada, Takeshi Masuda, et al.. (2016). Inhibition of PAI-1 Limits Tumor Angiogenesis Regardless of Angiogenic Stimuli in Malignant Pleural Mesothelioma. Cancer Research. 76(11). 3285–3294. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact